SecBot SecBot
Insider Cluster (2 insiders) ·Filed Aug 3, 2026

ALKS

Alkermes plc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago
Insider cluster: 2 insiders, $536K total
Actionable Insight • Neutral

The insider sales are too small to convey a material signal. Monitor for larger insider transactions or changes in guidance that could indicate management's view on the business trajectory.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$49.67
T+0 close · Aug 3, 2026 · via day close
Latest settled
−10.77%
T+60 · $44.32
Vs SPY
−11.15%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 4 $49.67entry
  2. T+1 · 3mo ago −0.12%α +0.08% · $49.61
  3. T+5 · 3mo ago −0.93%α −0.83% · $49.21
  4. T+20 · 3mo ago −4.97%α −3.73% · $47.20
  5. T+60 · 20d ago −10.77%α −11.15% · $44.32
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two Alkermes executives (EVP CLO and EVP R&D/CMO) sold a combined $536K in open-market shares on August 3, 2026, one week after the company reported a Q2 EPS miss and widened GAAP net loss guidance. The sales are trivial relative to the $8.2B market cap (0.0065%) and likely represent routine post-earnings transactions rather than a bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$536.0K
Insiders
2

Key Facts

  • EVP CLO David Gaffin sold 2,034 shares at $48.58 for ~$99K
  • EVP R&D/CMO Craig Hopkinson sold 9,000 shares at $48.58 for ~$437K
  • Total open-market sales of $536K represent 0.0065% of Alkermes' $8.2B market cap
  • Sales occurred 7 days after Q2 2026 earnings miss (EPS $0.00 vs $0.29 consensus) and widened GAAP net loss guidance

Financial Impact

Total open-market sales of $536K represent 0.0065% of $8.2B market cap, immaterial.

insider selling

Risk Factors

  • Insider sales could accelerate if Q3 results disappoint further
  • GAAP net loss guidance widening may pressure the stock if not offset by LUMRYZ revenue growth

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
83% bullish (23 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ALKS-1785801678578

Track record

23 reports on ALKS

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +25.88% at T+60 after the May 12, 2026 report. 3 of 4 went positive at some point.

Filters
  1. Nov 12, 20264d ago 8-K Neutral 4/10 Entry $46.98 Now $46.53 −0.96% settles Feb 10
  2. Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $44.54 Now $46.53 +4.47% settles Feb 3
  3. Nov 3, 202613d ago 144 Neutral 2/10 Entry $45.89 Now $46.53 +1.39% settles Feb 2
  4. Nov 3, 202613d ago 8-K Neutral 5/10 Entry $45.69 Now $46.53 +1.84% settles Feb 1
  5. Sep 21, 20268w ago 8-K Bullish 6/10 Entry $44.00 Now $46.53 +5.76% settles Dec 15
  6. Sep 16, 20268w ago 8-K Neutral 2/10 Entry $46.07 Now $46.53 +1.00% settles Dec 10
  7. Sep 3, 202610w ago Insider Cluster Neutral 2/10 Entry $46.10 Now $46.53 +0.93% settles Dec 1
  8. Aug 3, 202615w ago Insider Cluster Bearish 4/10 Entry $49.67 to $44.32 Now $46.53 +6.32% ▲ +10.77% +11.15% vs SPY
  9. Aug 3, 202615w ago Insider Cluster Neutral 2/10 Viewing Entry $49.67 to $44.32 Now $46.53 −6.32% ▼ −10.77% −11.15% vs SPY
  10. Aug 3, 202615w ago Insider Cluster Neutral 3/10 Entry $49.67 to $44.32 Now $46.53 −6.32% ▼ −10.77% −11.15% vs SPY
Showing 10 of 23

US Market Status

Market Closed · Opens Wed (10h 10m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 3, 2026